CalciMedica raises $1.5M for inflammatory disease
CalciMedica, a San Diego biotech focused on autoimmune and inflammatory disease, raised $1.53 million in a first funding round, PE Hub reports, citing a regulatory filing. S.R. One provided the funding.
Next Story: Roundup: Murdoch closer on WSJ, Scoop Bar, Wikia-Grub, Hitachi and more
Previous Story: Berggi, which makes "dumb" phones "smart," raises cash
About the Author, David P. Hamilton
David Hamilton has been writing for VentureBeat LifeScience since April 2007. He formerly spent 14 years as a reporter for the Wall Street Journal in its San Francisco and Tokyo bureaus. Prior to that, he spent several years as a reporter at Science Magazine and as a reporter/researcher for the New Republic, both in Washington.
